To further address the role of SIRT5 in leukemia progression in human B-ALL xenografts, stable SIRT5-knockdown or control Nalm-6-6-MPR cell lines were transplanted into M-NSG mice, and mouse leukemia progression was monitored (Fig. 6A). Here, SIRT5 is linked to acute lymphoblastic leukemia.